As Ozempic gains popularity, a skin-care category catering to GLP-1 users is inevitable

1 month ago 12

A skin-care category catering to GLP-1 users is likely on the horizon.

As of this summer, approximately one in eight Americans, or around 15 million people, have used Ozempic or other GLP-1 drugs, according to survey data from KFF, a nonprofit that provides information on health policy and polling. While many GLP-1 drugs are FDA-approved to treat type 2 diabetes and other health issues, the survey found that two in five Americans using the drug are doing so “off label” solely to lose weight.

GLP-1s like Ozempic, Wegovy and Mounjaro were approved by the FDA in 2017, 2021 and 2022, respectively, and in just a few short years have become commonplace in popular culture. According to data released in February by the Pew Research Center, about 75% of Americans are familiar with GLP-1s and more than half believe they are good options to lose weight for those with obesity or weight-related health conditions.

Continue reading this article on glossy.co. Sign up for Glossy newsletters to get the latest on the business of beauty, fashion and pop culture.

Article From: www.glossy.co

Read Entire Article

Note:

We invite you to explore our website, engage with our content, and become part of our community. Thank you for trusting us as your go-to destination for news that matters.

Certain articles, images, or other media on this website may be sourced from external contributors, agencies, or organizations. In such cases, we make every effort to provide proper attribution, acknowledging the original source of the content.

If you believe that your copyrighted work has been used on our site in a way that constitutes copyright infringement, please contact us promptly. We are committed to addressing and rectifying any such instances

To remove this article:
Removal Request